PolyModels Hub
Collaborative platform digitizing pharmaceutical process development and simulation.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | £1.1m | Seed | |
| Total Funding | 000k | ||
Related Content
PolyModels Hub is a London-based company founded in 2022 that provides a digital platform, ModelFlow, to accelerate drug development for the pharmaceutical industry. The company was established by Antonio Benedetti (CEO), Harry Christodoulou (Director of Modelling & Science), and Antonio Yankey (Director of Tech & Product). The founders possess a blend of chemical and software engineering expertise, with Benedetti and Christodoulou having previously worked at the intersection of pharma R&D and manufacturing at GlaxoSmithKline (GSK).
The firm's core offering, ModelFlow, is a collaborative platform that integrates modeling, simulations, scientific data, and insights into a single product. It is designed to be the digital backbone for pharma process development, allowing scientists, digital teams, and stakeholders to manage the entire lifecycle of a drug, from initial design to manufacturing and regulatory filing. By using AI tools and a library of model-based workflows, the platform enables in-silico simulations for new and existing medicines, which helps in making key decisions about a drug's quality attributes. This digital approach aims to replace paper-based systems and manual processes, thereby reducing development timelines, saving costs, and improving knowledge transfer for future products.
PolyModels Hub serves pharmaceutical companies by providing its software platform and professional services to help them adopt digital tools. The company has partnered with several leading pharmaceutical companies to implement its digital design and simulation solutions. In July 2024, the company announced it had raised £1.1 million in a seed funding round led by Marathon Venture Capital to enhance its platform and expand its team.
Keywords: pharma process development, drug development software, modeling and simulation, digital drug design, life sciences technology, ModelFlow platform, in-silico simulation, pharmaceutical R&D, chemical engineering, AI in pharma, drug lifecycle management, regulatory compliance tools, scientific data integration, collaborative pharma platform, biotech software, therapeutic modalities, computational fluid dynamics, knowledge transfer platform, life sciences, drug portfolio management